Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer I Lim

Showing results (171-180 of 190) with videos related to

Pageof 19
Sort By:
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 7, 2024
Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomesHansjürgen Agostini, Francis Abreu, Caroline R Baumal, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 13, 2005
Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trialMohammad Azab, David S Boyer, Neil M Bressler, et al.
Ophthalmology|February 21, 2024
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2Arshad M Khanani, Aachal Kotecha, Andrew Chang, et al.
Ophthalmology|November 25, 2006
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema, David J Browning, Adam R Glassman, et al.
Signal Transduction and Targeted Therapy|October 21, 2025
Proliferative diabetic retinopathy subtypes defined by immune defense and endothelial mitochondrial dysfunctionMaximilian A McCann, Basma Baccouche, Yueru Li, et al.
Journal of Vitreoretinal Diseases|August 5, 2025
The Influence of Ultra-Wide field Fluorescein Angiography on the Diagnosis and Management of Diabetic RetinopathyNicole K Scripsema, Tala Al-Khaled, Amy Song, et al.
Retina (Philadelphia, Pa.)|April 13, 2004
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4Mohammad Azab, Mustapha Benchaboune, Kevin J Blinder, et al.
Ophthalmology|April 12, 2003
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3Kevin J Blinder, Mark S Blumenkranz, Neil M Bressler, et al.
Ophthalmology|September 22, 2010
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) studyQuan Dong Nguyen, Syed Mahmood Shah, Afsheen A Khwaja, et al.
American Journal of Ophthalmology|October 9, 2025
International Consensuses and Guidelines on the Etiology, Diagnosis and Management of Intraocular Foreign Bodies (IOFBs) by the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), the Asia-Pacific Vitreo-retina Society (APVRS), and the Academia Retina Internationalis (ARI)Kenneth K W Li, Daniel H T Wong, Andrea C K Au, et al.
Pageof 19

Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 7, 2024
Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomesHansjürgen Agostini, Francis Abreu, Caroline R Baumal, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 13, 2005
Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trialMohammad Azab, David S Boyer, Neil M Bressler, et al.
Ophthalmology|February 21, 2024
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2Arshad M Khanani, Aachal Kotecha, Andrew Chang, et al.
Ophthalmology|November 25, 2006
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema, David J Browning, Adam R Glassman, et al.
Signal Transduction and Targeted Therapy|October 21, 2025
Proliferative diabetic retinopathy subtypes defined by immune defense and endothelial mitochondrial dysfunctionMaximilian A McCann, Basma Baccouche, Yueru Li, et al.
Journal of Vitreoretinal Diseases|August 5, 2025
The Influence of Ultra-Wide field Fluorescein Angiography on the Diagnosis and Management of Diabetic RetinopathyNicole K Scripsema, Tala Al-Khaled, Amy Song, et al.
Retina (Philadelphia, Pa.)|April 13, 2004
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4Mohammad Azab, Mustapha Benchaboune, Kevin J Blinder, et al.
Ophthalmology|April 12, 2003
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3Kevin J Blinder, Mark S Blumenkranz, Neil M Bressler, et al.
Ophthalmology|September 22, 2010
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) studyQuan Dong Nguyen, Syed Mahmood Shah, Afsheen A Khwaja, et al.
American Journal of Ophthalmology|October 9, 2025
International Consensuses and Guidelines on the Etiology, Diagnosis and Management of Intraocular Foreign Bodies (IOFBs) by the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), the Asia-Pacific Vitreo-retina Society (APVRS), and the Academia Retina Internationalis (ARI)Kenneth K W Li, Daniel H T Wong, Andrea C K Au, et al.
Pageof 19